Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre-Seasonal Short Courses of Allergen-Specific Immunotherapy: A Long-Term Open-Label Extension Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Same author

Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.

Allergy·2026

Same author

Trends and Patterns for the Use of Herbal Medicinal Products for Gynaecological Ailments.

Phytotherapy research : PTR·2026

Same author

Allergen Immunotherapy with Depigmented-Polymerised Cat Allergoid Is Safe and Well-Tolerated in Patients with Allergic Rhinitis/Rhinoconjunctivitis.

Journal of clinical medicine·2025

Same author

Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment.

Journal of clinical medicine·2025

Same author

<i>In-vivo</i> allergen extract potency is maintained in a sublingual immunotherapy maintenance vial of pollens and mites.

Allergy and asthma proceedings·2025

Search research articles

Related Experiment Video

Updated: Aug 25, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

MicroCrystalline Tyrosine-adsorbed immunotherapy.

Helal Al Saleh¹, Ralph Mösges²

¹Department of Otolaryngology, Faculty of Medicine, University of Damascus, Damascus, Syria.

Current Opinion in Allergy and Clinical Immunology

|October 18, 2022

Summary

MicroCrystalline Tyrosine (MCT) shows promise in immunotherapy, demonstrating effectiveness and safety. Recent studies highlight its potential for sustained effects and in disease models like malaria and melanoma.

More Related Videos

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Related Experiment Videos

Last Updated: Aug 25, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Area of Science:

Immunology and Vaccinology
Adjuvant Technology

Background:

Immunotherapy aims to harness the immune system for therapeutic benefit.
Adjuvants are crucial for enhancing vaccine efficacy and immune response.
MicroCrystalline Tyrosine (MCT) is an emerging adjuvant with potential applications.

Conclusions:

MCT is a safe and effective adjuvant for immunotherapy.
Its depot formulation offers sustained immune stimulation.
MCT holds promise for various therapeutic applications and disease prevention.